Cambridge Trust’s Blonder Tongue Laboratories Inc BDR Stock Holding History

Cambridge Trust’s Portfolio BDR Stock Details BDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-13,001	Closed	-$10K	–	282
2019 Q4	$10K	Buy	+13,001	New	+$8.87K	﹤0.01%	279

Other funds holding BDR

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Cambridge Trust's BDR Position: Q1 2020 in Review

Cambridge Trust sold out of Blonder Tongue Laboratories Inc (BDR) in Q1 2020, closing a stake of 13,001 shares — an estimated $10K sold.

Cambridge Trust first reported a position in BDR in Q4 2019 and held it in 1 quarter. The position peaked at $10K in Q4 2019. 7 funds tracked by Wall St. Rank hold BDR as of Q1 2020.

Cambridge Trust reported no remaining Blonder Tongue Laboratories Inc position as of Q1 2020 after selling out during the quarter.
Cambridge Trust sold 13,001 Blonder Tongue Laboratories Inc shares in Q1 2020, an estimated $10K.
Cambridge Trust first reported a position in Blonder Tongue Laboratories Inc in Q4 2019 and held it in 1 quarter.
Cambridge Trust's Blonder Tongue Laboratories Inc position peaked at $10K in Q4 2019.
7 funds tracked by Wall St. Rank held Blonder Tongue Laboratories Inc as of Q1 2020.

Based on Cambridge Trust's 13F filing for Q1 2020, filed 4 May 2020.